Described herein are pharmaceutical packaging programs which prevent oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive medicines, such methods which includes a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with really small permeability to oxygen and compris… Read More